F.D.A. Approves Narcan for Over-the-Counter Salesnews2023-03-29T12:45:40+00:00March 29th, 2023|The New York Times|
Over-the-Counter Narcan Could Save More Lives. But Price and Stigma Are Obstacles.news2023-03-28T17:05:40+00:00March 28th, 2023|The New York Times|
¿Podría el próximo fármaco de éxito conseguirse sin ratas de laboratorio?news2023-03-12T10:00:10+00:00March 12th, 2023|The New York Times|
Could the Next Blockbuster Drug Be Lab-Rat Free?news2023-03-07T08:00:08+00:00March 7th, 2023|The New York Times|
A Statin Alternative Joins Drugs That Can Reduce Heart Attack Risknews2023-03-04T16:58:34+00:00March 4th, 2023|The New York Times|
Walgreens Says It Won’t Offer the Abortion Pill Mifepristone in Conservative Statesnews2023-03-03T22:35:56+00:00March 3rd, 2023|The New York Times|
Opioid Distributors Cleared of Liability to Georgia Families Ravaged by Addictionnews2023-03-02T02:54:45+00:00March 2nd, 2023|The New York Times|
After Long Delay, Moderna Pays N.I.H. for Covid Vaccine Techniquenews2023-02-23T23:25:31+00:00February 23rd, 2023|The New York Times|
Narcan Is Safe to Sell Over the Counter, Advisers to the FDA Concludenews2023-02-16T01:23:11+00:00February 16th, 2023|The New York Times|
The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?news2023-01-18T21:26:06+00:00January 18th, 2023|The New York Times|
